Nxera Pharma to receive USD 8.6 million milestone payment from Centessa

Reuters2026/09/03 06:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nxera Pharma will receive a USD 8.6 million milestone payment from Centessa tied to late-stage development progress in its OX2R agonist portfolio.
Revenue recognition set for Q3 of the fiscal year ending Dec. 31, 2026.
Lilly completed its acquisition of Centessa on June 24, 2026, transferring ownership of the OX2R agonist pipeline.
Nxera retains rights to future development milestones, commercialization milestones, royalties linked to the programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nxera Pharma Co. Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030234PRIMZONEFULLFEED1001260778) on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nxera Pharma to receive USD 8.6 million milestone payment from Centessa

You may also like

Crypto prices